⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRAX News
Praxis Precision Medicines, Inc. Common Stock
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Provides Vormatrigine Program Update
globenewswire.com
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
globenewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
globenewswire.com
PRAX
Alan Draper Named Chief Executive Officer of Nippon Sanso Matheson
businesswire.com
LIN
PRAX
KCNQ2 Developmental and Epileptic Encephalopathy Market Research Report 2025-2035, Competitive Analysis of Biohaven, Xenon Pharma, Lundbeck, Praxis Precision Medicines, NeuShen Therapeutics
globenewswire.com
BHVN
XENE
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
globenewswire.com
PRAX